Kwok-Yung Yuen to SARS Virus
This is a "connection" page, showing publications Kwok-Yung Yuen has written about SARS Virus.
Connection Strength
2.540
-
Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19. Clin Infect Dis. 2020 09 12; 71(6):1400-1409.
Score: 0.161
-
Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events. J Virol. 2010 Mar; 84(6):2808-19.
Score: 0.077
-
Viral loads in clinical specimens and SARS manifestations. Hong Kong Med J. 2009 Dec; 15 Suppl 9:20-2.
Score: 0.076
-
An oral mucosal DNA vaccine for SARS coronavirus infections. Hong Kong Med J. 2009 Feb; 15 Suppl 2:41-2.
Score: 0.072
-
Studies of SARS virus vaccines. Hong Kong Med J. 2008 Aug; 14 Suppl 4:39-43.
Score: 0.069
-
The management of coronavirus infections with particular reference to SARS. J Antimicrob Chemother. 2008 Sep; 62(3):437-41.
Score: 0.069
-
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007 Oct; 20(4):660-94.
Score: 0.065
-
Nasopharyngeal detection of severe acute respiratory syndrome-associated coronavirus RNA in health-care workers. Chest. 2006 Jan; 129(1):12-3.
Score: 0.058
-
SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Vaccine. 2005 Oct 10; 23(42):4959-68.
Score: 0.057
-
The severe acute respiratory syndrome (SARS). J Neurovirol. 2005 Oct; 11(5):455-68.
Score: 0.057
-
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci U S A. 2005 Sep 27; 102(39):14040-5.
Score: 0.057
-
SARS coronavirus detection methods. Emerg Infect Dis. 2005 Jul; 11(7):1108-11.
Score: 0.056
-
Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43. J Infect Dis. 2005 Jun 15; 191(12):2033-7.
Score: 0.055
-
Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E. J Virol. 2005 May; 79(10):6180-93.
Score: 0.055
-
Duration of RT-PCR positivity in severe acute respiratory syndrome. Eur Respir J. 2005 Jan; 25(1):12-4.
Score: 0.054
-
False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. J Clin Microbiol. 2004 Dec; 42(12):5885-8.
Score: 0.054
-
Initial viral load and the outcomes of SARS. CMAJ. 2004 Nov 23; 171(11):1349-52.
Score: 0.054
-
Nucleocapsid protein as early diagnostic marker for SARS. Emerg Infect Dis. 2004 Nov; 10(11):1947-9.
Score: 0.053
-
Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay. FEBS Lett. 2004 Oct 22; 576(3):325-30.
Score: 0.053
-
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol. 2004 Sep; 31(1):69-75.
Score: 0.053
-
Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. Chem Biol. 2004 Sep; 11(9):1293-9.
Score: 0.053
-
Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis. 2004 Sep; 10(9):1550-7.
Score: 0.053
-
Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin Diagn Lab Immunol. 2004 Jul; 11(4):665-8.
Score: 0.052
-
Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay. J Clin Microbiol. 2004 Jul; 42(7):2884-9.
Score: 0.052
-
Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome. J Clin Microbiol. 2004 Jun; 42(6):2629-35.
Score: 0.052
-
Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol. 2004 May; 42(5):2306-9.
Score: 0.052
-
Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome. Clin Infect Dis. 2004 Feb 15; 38(4):467-75.
Score: 0.051
-
Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction. Emerg Microbes Infect. 2020 Dec; 9(1):837-842.
Score: 0.041
-
Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target. Emerg Microbes Infect. 2020 Dec; 9(1):2663-2672.
Score: 0.041
-
SARS-CoV-2 Induces a More Robust Innate Immune Response and Replicates Less Efficiently Than SARS-CoV in the Human Intestines: An Ex Vivo Study With Implications on Pathogenesis of COVID-19. Cell Mol Gastroenterol Hepatol. 2021; 11(3):771-781.
Score: 0.040
-
Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-ß and IFN inducer. J Infect. 2020 10; 81(4):e1-e10.
Score: 0.040
-
Disinfection of N95 respirators by ionized hydrogen peroxide during pandemic coronavirus disease 2019 (COVID-19) due to SARS-CoV-2. J Hosp Infect. 2020 Jun; 105(2):358-359.
Score: 0.039
-
SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet. 2020 03 21; 395(10228):949-950.
Score: 0.039
-
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 2019 02 21; 4(4).
Score: 0.036
-
Replication of MERS and SARS coronaviruses in bat cells offers insights to their ancestral origins. Emerg Microbes Infect. 2018 Dec 10; 7(1):209.
Score: 0.036
-
Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3. Emerg Microbes Infect. 2016 Apr 20; 5:e39.
Score: 0.030
-
Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination. J Virol. 2015 Oct; 89(20):10532-47.
Score: 0.028
-
Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways. J Infect Dis. 2016 Mar 15; 213(6):904-14.
Score: 0.028
-
Wild animal surveillance for coronavirus HKU1 and potential variants of other coronaviruses. Hong Kong Med J. 2012 Feb; 18 Suppl 2:25-6.
Score: 0.022
-
Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by SARS coronavirus and human coronavirus 229E. Hong Kong Med J. 2009 Dec; 15 Suppl 9:23-6.
Score: 0.019
-
Development of interfering RNA agents to inhibit SARS-associated coronavirus infection and replication. Hong Kong Med J. 2009 Jun; 15(3 Suppl 4):28-31.
Score: 0.018
-
Expression, crystallization and preliminary crystallographic study of human coronavirus HKU1 nonstructural protein 9. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 May 01; 65(Pt 5):526-8.
Score: 0.018
-
Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex. J Biol Chem. 2009 Jun 12; 284(24):16202-16209.
Score: 0.018
-
Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Vaccine. 2008 Mar 20; 26(13):1644-51.
Score: 0.017
-
Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines. Virology. 2006 Sep 15; 353(1):6-16.
Score: 0.015
-
Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J Med Virol. 2006 Jan; 78(1):1-8.
Score: 0.014
-
Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Clin Diagn Lab Immunol. 2005 Nov; 12(11):1317-21.
Score: 0.014
-
[Cloning, purification, and antigenic characterization of three recombinant fragments derived from SARS-CoV S1 domain]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005 Sep; 19(3):275-8.
Score: 0.014
-
Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol. 2005 Jul; 43(7):3054-8.
Score: 0.014
-
Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol. 2005 Jun; 79(12):7819-26.
Score: 0.014
-
Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periods. J Clin Virol. 2005 May; 33(1):19-24.
Score: 0.014
-
Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E. J Gen Virol. 2005 May; 86(Pt 5):1423-1434.
Score: 0.014
-
Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J Virol. 2005 Mar; 79(5):2678-88.
Score: 0.014
-
Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus. Antivir Ther. 2005; 10(3):393-403.
Score: 0.014
-
A one step quantitative RT-PCR for detection of SARS coronavirus with an internal control for PCR inhibitors. J Clin Virol. 2004 Jul; 30(3):214-7.
Score: 0.013
-
Reverse transcriptase PCR diagnostic assay for the coronavirus associated with severe acute respiratory syndrome. J Clin Microbiol. 2004 May; 42(5):1994-9.
Score: 0.013
-
Rapid detection of the severe acute respiratory syndrome (SARS) coronavirus by a loop-mediated isothermal amplification assay. Clin Chem. 2004 Jun; 50(6):1050-2.
Score: 0.013
-
Coronavirus infection in an AIDS patient. AIDS. 2004 Mar 26; 18(5):829-30.
Score: 0.013
-
Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome. Lancet. 2004 Jan 10; 363(9403):99-104.
Score: 0.013
-
Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. Clin Chem. 2004 Jan; 50(1):67-72.
Score: 0.013
-
Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein. Di Yi Jun Yi Da Xue Xue Bao. 2004 Jan; 24(1):1-6.
Score: 0.013
-
Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol. 2003 Dec; 28(3):233-8.
Score: 0.013
-
Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong. Lancet. 2003 Nov 29; 362(9398):1807-8.
Score: 0.013
-
Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet. 2003 Oct 25; 362(9393):1353-8.
Score: 0.012
-
Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003 Oct 10; 302(5643):276-8.
Score: 0.012
-
The complete genome sequence of severe acute respiratory syndrome coronavirus strain HKU-39849 (HK-39). Exp Biol Med (Maywood). 2003 Jul; 228(7):866-73.
Score: 0.012
-
Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS). Clin Chem. 2003 Jun; 49(6 Pt 1):953-5.
Score: 0.012
-
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003 May 24; 361(9371):1767-72.
Score: 0.012
-
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell. 2020 05 14; 181(4):894-904.e9.
Score: 0.010
-
Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J. 2019 08; 33(8):8865-8877.
Score: 0.009
-
A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses. Sci Rep. 2016 Feb 25; 6:22008.
Score: 0.007
-
Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection. J Immunol. 2008 Jan 15; 180(2):948-56.
Score: 0.004
-
Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2006 Sep; 80(18):9279-87.
Score: 0.004
-
Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol. 2005 Oct; 3(10):e324.
Score: 0.004
-
The aetiology, origins, and diagnosis of severe acute respiratory syndrome. Lancet Infect Dis. 2004 Nov; 4(11):663-71.
Score: 0.003
-
Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J Clin Microbiol. 2003 Oct; 41(10):4521-4.
Score: 0.003